Beyond the Pharmacopoeia: To what extent is trade for “TCM” limited to official TCM taxa?

The global trade in wildlife affects ~24% of terrestrial vertebrates, and demand for traditional medicinal materials, especially for traditional Chinese medicine, is a high profile driver. At present the relative extent to which demand for wild-animal-origin medicinal materials arises from different...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tom P. Moorhouse, Angie Elwin, Yun-Chun Ye, Zhao-Min Zhou, Neil C.D. Cruze, David W. Macdonald
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Chinese Medicine Official TCM (OTCM) Species conservation Animal welfare Plant-origin alternative Ecology QH540-549.5
Acceso en línea:	https://doaj.org/article/80cbe09b884544b2a2231ac00f3c0e96
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:80cbe09b884544b2a2231ac00f3c0e96
record_format	dspace
spelling	oai:doaj.org-article:80cbe09b884544b2a2231ac00f3c0e962021-11-12T04:37:16ZBeyond the Pharmacopoeia: To what extent is trade for “TCM” limited to official TCM taxa?2351-989410.1016/j.gecco.2021.e01906https://doaj.org/article/80cbe09b884544b2a2231ac00f3c0e962021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S235198942100456Xhttps://doaj.org/toc/2351-9894The global trade in wildlife affects ~24% of terrestrial vertebrates, and demand for traditional medicinal materials, especially for traditional Chinese medicine, is a high profile driver. At present the relative extent to which demand for wild-animal-origin medicinal materials arises from different markets (OTCM, zhongyi and CMP, see companion paper) within ''TCM'' is unknown. We wished to populate the above categories, revealing the numbers and types of species involved, to provide the first consolidated description of the diversity of animal species potentially able to be used for different facets of ''TCM”, an overview of their conservation status, and an initial estimate of the degree to which existing trade feeds into these different facets of ''TCM”. We found that the number and diversity of wild-animal-origin medicinal materials listed as available for use in ''TCM'' differ markedly between the Pharmacopoeia of the People’s Republic of China (representing OTCM) - which currently lists 70 wild species - and the Medical Fauna of China, representing zhongyi - which lists 2275 animal species. Our findings indicated a substantial trade - both imports to, and exports from China - of ''TCM'' medicinal materials from wild animal taxa listed in the Medical Fauna of China but not listed in the Pharmacopoeia, and also of species for which there is no prior textual support, including species potentially being traded as substitutes for listed species. We recommend working with TCM practitioners to enact the targeted substitution of sustainably sourced plant-based medicinal materials for the currently-used animal-origin materials. We suggest that this should initially target the 70 OTCM species, as well as inferred OTCM species and selected genera likely to be imported as substitutes, to strike a balance between keeping the focus of the required research narrow, while targeting the taxa most likely to be traded.Tom P. MoorhouseAngie ElwinYun-Chun YeZhao-Min ZhouNeil C.D. CruzeDavid W. MacdonaldElsevierarticleChinese MedicineOfficial TCM (OTCM)Species conservationAnimal welfarePlant-origin alternativeEcologyQH540-549.5ENGlobal Ecology and Conservation, Vol 32, Iss , Pp e01906- (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Chinese Medicine Official TCM (OTCM) Species conservation Animal welfare Plant-origin alternative Ecology QH540-549.5
spellingShingle	Chinese Medicine Official TCM (OTCM) Species conservation Animal welfare Plant-origin alternative Ecology QH540-549.5 Tom P. Moorhouse Angie Elwin Yun-Chun Ye Zhao-Min Zhou Neil C.D. Cruze David W. Macdonald Beyond the Pharmacopoeia: To what extent is trade for “TCM” limited to official TCM taxa?
description	The global trade in wildlife affects ~24% of terrestrial vertebrates, and demand for traditional medicinal materials, especially for traditional Chinese medicine, is a high profile driver. At present the relative extent to which demand for wild-animal-origin medicinal materials arises from different markets (OTCM, zhongyi and CMP, see companion paper) within ''TCM'' is unknown. We wished to populate the above categories, revealing the numbers and types of species involved, to provide the first consolidated description of the diversity of animal species potentially able to be used for different facets of ''TCM”, an overview of their conservation status, and an initial estimate of the degree to which existing trade feeds into these different facets of ''TCM”. We found that the number and diversity of wild-animal-origin medicinal materials listed as available for use in ''TCM'' differ markedly between the Pharmacopoeia of the People’s Republic of China (representing OTCM) - which currently lists 70 wild species - and the Medical Fauna of China, representing zhongyi - which lists 2275 animal species. Our findings indicated a substantial trade - both imports to, and exports from China - of ''TCM'' medicinal materials from wild animal taxa listed in the Medical Fauna of China but not listed in the Pharmacopoeia, and also of species for which there is no prior textual support, including species potentially being traded as substitutes for listed species. We recommend working with TCM practitioners to enact the targeted substitution of sustainably sourced plant-based medicinal materials for the currently-used animal-origin materials. We suggest that this should initially target the 70 OTCM species, as well as inferred OTCM species and selected genera likely to be imported as substitutes, to strike a balance between keeping the focus of the required research narrow, while targeting the taxa most likely to be traded.
format	article
author	Tom P. Moorhouse Angie Elwin Yun-Chun Ye Zhao-Min Zhou Neil C.D. Cruze David W. Macdonald
author_facet	Tom P. Moorhouse Angie Elwin Yun-Chun Ye Zhao-Min Zhou Neil C.D. Cruze David W. Macdonald
author_sort	Tom P. Moorhouse
title	Beyond the Pharmacopoeia: To what extent is trade for “TCM” limited to official TCM taxa?
title_short	Beyond the Pharmacopoeia: To what extent is trade for “TCM” limited to official TCM taxa?
title_full	Beyond the Pharmacopoeia: To what extent is trade for “TCM” limited to official TCM taxa?
title_fullStr	Beyond the Pharmacopoeia: To what extent is trade for “TCM” limited to official TCM taxa?
title_full_unstemmed	Beyond the Pharmacopoeia: To what extent is trade for “TCM” limited to official TCM taxa?
title_sort	beyond the pharmacopoeia: to what extent is trade for “tcm” limited to official tcm taxa?
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/80cbe09b884544b2a2231ac00f3c0e96
work_keys_str_mv	AT tompmoorhouse beyondthepharmacopoeiatowhatextentistradefortcmlimitedtoofficialtcmtaxa AT angieelwin beyondthepharmacopoeiatowhatextentistradefortcmlimitedtoofficialtcmtaxa AT yunchunye beyondthepharmacopoeiatowhatextentistradefortcmlimitedtoofficialtcmtaxa AT zhaominzhou beyondthepharmacopoeiatowhatextentistradefortcmlimitedtoofficialtcmtaxa AT neilcdcruze beyondthepharmacopoeiatowhatextentistradefortcmlimitedtoofficialtcmtaxa AT davidwmacdonald beyondthepharmacopoeiatowhatextentistradefortcmlimitedtoofficialtcmtaxa
_version_	1718431239222853632

Beyond the Pharmacopoeia: To what extent is trade for “TCM” limited to official TCM taxa?

Ejemplares similares